Serum Institute of India

Serum Institute of India

Serum Institute of India is a company that manufactures vaccines and other pharmaceutical products

Serum Institute of India is a company that manufactures vaccines and other pharmaceutical products. The company was founded in 1996 in Pune, Maharashtra, India.

Serum Institute of India claims to be the largest vaccine manufacturer by number of doses. They have produced and sold over 1.5 billion doses of vaccines around the world. The company has manufacture vaccines for Polio, Diphtheria, Tetanus, Perussis, Hib, BCG, r-Hepatitis B, Measles, Mumps, and Rubella diseases.

COVID-19

With the outbreak of COVID-19 (coronavirus), Serum Institute of India has claimed to have found a breakthrough in developing a vaccine for the contagion. Their virus-vaccine strain has reached animal clinical trial stages. They expect results from these trials within two months.

The company has partnered with a US-based biotech drug research company, Codagenix, to develop a vaccine to fight the coronavirus. The company claims it is the first vaccine to move from the laboratory to pre-clinical trial phase and they expect the product to be ready by 2022.

Timeline

People

Name
Role
LinkedIn

Adar Poonawalla

CEO

Cyrus Poonawalla

Managing Director

Further reading

Title
Author
Link
Type
Date

About Serum Institute Of India Pvt. Ltd.

Web

Serum Institute of India | Manufacturer of Vaccines & immuno-biologicals - GMP Vaccine Manufacturer

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Serum Institute of India

Adar Poonwalla

Pune, Maharashtra, India

Biotechnology, pharmaceuticals

News

Title
Author
Date
Publisher
Description
Sohini Das
March 1, 2021
@bsindia
AstraZeneca Chief Executive (CEO) Pascal Soriot has indicated that the company may look at factories outside of the EU to meet the supply commitments.
Sohini Das
February 22, 2021
@bsindia
Bharat Bio says keen to follow, have capacity of 40 mn doses a month
Sohini Das
February 19, 2021
@bsindia
Novavax has signed a memorandum of understanding (MoU) in this regard with Gavi, the Vaccine Alliance.
T E Narasimhan
February 19, 2021
@bsindia
Litigant is a Chennai-based consultant who volunteered for the trial. Claims he suffered side effects, for which he sought a compensation of Rs 5 cr
Sohini Das
February 9, 2021
@bsindia
Home-grown firms get new orders: 10 million for SII, 4.5 million for Bharat Bio
The Hindu Net Desk
January 31, 2021
The Hindu
A video taking about Pune-based vaccine manufacturer Serum Institute of India
R. Prasad
January 30, 2021
The Hindu
Oxford University and AstraZeneca committed on multiple occasions to supply the vaccine on a not-for-profit basis
ANI
January 30, 2021
@bsindia
SII is already manufacturing millions of doses of Covishield vaccine in technical collaboration with Oxford University and AstraZeneca
Sohini Das
January 25, 2021
@bsindia
NeuroRx and Relief Therapeutics have partnered to develop a drug called RLF-100 that has anti-inflammatory and anti-cytokine activity properties.
Press Trust of India
January 23, 2021
@bsindia
A major fire had broken out two days ago, killing five persons
Press Trust of India
January 22, 2021
@bsindia
A probe is on to ascertain the cause of the blaze that killed five workers at Serum Institute of Indias premises here
ANI
January 22, 2021
@bsindia
The forensic team visited the incident site to collect samples for investigation
January 22, 2021
The Economic Times
Five labourers died in the fire which broke out in a five-storeyed under-construction building in the Serum Institute of India's Manjari premises in Pune.
Press Trust of India
January 22, 2021
@bsindia
Five men died after a fire broke out in a five-storeyed under-construction building in the Serum Institute of Indias Manjari premises in Pune on Thursday, police said
Ruchika Chitravanshi & Aneesh Phadnis
January 21, 2021
@bsindia
Prime Minister Narendra Modi expressed anguish over the incident
BS Web Team
January 21, 2021
@bsindia
Videos and pictures from showed black smoke billowing out of a grey building in Serum Institutes headquarters
Reuters
January 21, 2021
@bsindia
SII is manufacturing a vaccine developed by Oxford University and AstraZeneca
IANS
January 21, 2021
@bsindia
India is shipping vaccines free of cost to many of its neighbours
Archana Chaudhary and P R Sanjai | Bloomberg
January 20, 2021
@bsindia
Serum, the worlds largest producer of vaccines by volume, can ship out the Astra vaccine priced between $5-10 per dose
Press Trust of India
January 19, 2021
@bsindia
Serum Institute of India (SII) is manufacturing anti-coronavirus vaccine called Covishield
SHOW MORE

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.